Bishal Gyawali: Honoured to lead patient-directed cancer therapy program
Bishal Gyawali, Associate Professor at Queen’s University, shared a post by Queen’s Health Sciences on X, adding:
“Incredibly honoured and grateful to have received this funding from Marathon of Hope. A funding conceived by patients for patients and a project plan that includes patients. Looking forward to starting the work!”
Quoting Queen’s Health Sciences:
“Research is stronger when it’s shaped by those it impacts. Dr. Bishal Gyawali and a Queen’s Research team are leading a groundbreaking patient-directed program to develop therapies that address real patient needs and improve care outcomes. Learn more.”
Bishal Gyawali, MD, PhD, is a medical oncologist from Nepal. Currently an Associate Professor at Queen’s University, Kingston, Canada, and affiliated with Brigham and Women’s Hospital, Boston, USA, he is involved in global oncology initiatives. Dr. Gyawali serves on several committees, including the WHO Essential Medicines List Cancer Medicines Working Group and ASCO’s Health Equity and Outcomes Committee, contributing significantly to cancer policy and evidence-based oncology.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023